Press release
Dengue Fever - Pipeline Review, H1 2018
Dengue Fever
Request a sample report @ https://www.htfmarketreport.com/sample-report/1226081-dengue-fever-pipeline-review-4
Dengue Fever - Pipeline Review, H1 2018
HTF’s latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Pipeline Review, H1 2018, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape.
Dengue is a mosquito borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from nose, gums, or under skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of analgesics, fluid replacement therapy and healthy life style.
Report Highlights
HTF’s Pharmaceutical and Healthcare latest pipeline guide Dengue Fever - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Dengue Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Dengue Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 6, 24, 17 and 3 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 3, 13 and 12 molecules, respectively.
Dengue Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Dengue Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Dengue Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dengue Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dengue Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dengue Fever (Infectious Disease)
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1226081
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dengue Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dengue Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report
Abivax SA
Altravax Inc
Biological Mimetics Inc
Bioneer Corp
Biotron Ltd
Chugai Pharmaceutical Co Ltd
Emergex Vaccines Ltd
Ennaid Therapeutics LLC
GeneSegues Inc
GlaxoSmithKline Plc
Globavir Biosciences Inc
Immunotope Inc
Inovio Pharmaceuticals Inc
Johnson & Johnson
Kineta Inc
Merck & Co Inc
Novartis AG
NovaTarg Therapeutics Inc
Panacea Biotec Ltd
Plex Pharmaceuticals Inc
Shionogi & Co Ltd
SIGA Technologies Inc
Sun Pharma Advanced Research Company Ltd
Takeda Pharmaceutical Co Ltd
TechnoVax Inc
Visterra Inc
VLP Therapeutics LLC
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1226081-dengue-fever-pipeline-review-4
Introduction 5
Dengue Fever - Overview 6
Dengue Fever - Therapeutics Development 7
Dengue Fever - Therapeutics Assessment 18
Dengue Fever - Companies Involved in Therapeutics Development 26
Dengue Fever - Drug Profiles 38
Dengue Fever - Dormant Projects 132
Dengue Fever - Discontinued Products 137
Dengue Fever - Product Development Milestones 138
Appendix 149List of Tables
Number of Products under Development for Dengue Fever, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1226081-dengue-fever-pipeline-review-4
It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at
https://www.linkedin.com/company/13388569/
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Fever - Pipeline Review, H1 2018 here
News-ID: 1093191 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
AI Dashcam Market Next Big Thing | Major Giants Thinkware, Garmin, BlackVue, Roa …
HTF MI recently introduced Global AI Dashcam Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market size (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major Companies in AI Dashcam Market are: Garmin (US), BlackVue (South Korea), Nextbase (UK), Thinkware (South Korea), YI Technology (China), Rexing (US), Vantrue…
Creative handmade gifts Market Is Booming Worldwide | Major Giants Handmade at A …
HTF MI recently introduced Global Creative handmade gifts Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Creative handmade gifts Market are:
Etsy (USA), Amazon Handmade (USA), Handmade at Amazon (USA), ArtFire (USA), Zibbet (Australia),…
Women personal care Market Is Booming Worldwide | Major Giants Avon Products, Ki …
HTF MI recently introduced Global Women personal care Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Women personal care Market are:
L'Oréal (France), Unilever (UK/Netherlands), Procter & Gamble (USA), Estée Lauder (USA), Shiseido (Japan),…
Exotic Cars Market May See a Big Move | Major Giants Ferrari, Lamborghini, Rolls …
HTF MI just released the Global Exotic Cars Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Exotic Cars Market are:
Ferrari (Italy), Lamborghini (Italy), Porsche…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
